Devices/Safety Alert·openFDA/device

PUMP MMT-1880L MM770G BLE MG (MEDTRONIC PUERTO RICO OPERATIONS CO.) — Injury

MediumPublished Apr 30, 2026· AI-analyzed May 19, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

The FDA recorded an adverse event involving an injury associated with the PUMP MMT-1880L MM770G BLE MG manufactured by Medtronic Puerto Rico Operations Co. The source identifies the event type as an injury but does not specify the medical nature or cause of the incident.

Who it affects

This affects Medtronic Puerto Rico Operations Co., specifically personnel responsible for the MM770G product line, as well as regulatory compliance and clinical safety officers managing insulin delivery systems.

Why it matters

The classification of this event as an 'Injury' suggests a potential functional failure or user-interface issue that led to patient harm. While the source provides limited detail on the severity, this report indicates a post-market safety signal that may require a root cause analysis and could lead to increased regulatory scrutiny of the device's Bluetooth Low Energy (BLE) integration or pumping mechanism.

Practical takeaway

QA and post-market teams should review internal complaint handling for this specific model line and ensure timely reporting of similar events. Regulatory affairs should monitor for potential field safety corrective actions if injury patterns persist.

FDA source material

Event type: Injury. Device: PUMP MMT-1880L MM770G BLE MG by MEDTRONIC PUERTO RICO OPERATIONS CO..

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.